A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

Jan 17 (Reuters) - The U.S. Food and Drug Administration has ... Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions.

The Japanese government approved the breast cancer drug in late December. Jefferies analysts said in a note that they had assumed a 65% chance of FDA approval, but they believe that the market was ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer. The agent improved ... is a Trop-2-directed antibody-drug conjugate.

Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval ... designed to accelerate the approval process for certain oncology drugs or biologics that aim to address ...

Jan 16 (Reuters) - The U.S. Food and Drug ... approved to treat adult patients whose cancer has spread to other parts of the body despite receiving chemotherapy, the health regulator said. The FDA ...

The company is also seeking to expand use of the drug to other cancers. Last week, the FDA accepted an application seeking approval of the ADC for EGFR-mutated non-small cell lung cancer.

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on ...

A blockbuster AstraZeneca drug may now be used ... it the first in its class approved as a first-line therapy for this rare and aggressive type of blood cancer. The FDA expanded approval of ...

Johnson & Johnson has initiated an application seeking Food and Drug Administration approval of its TAR-200 drug-device combination for the treatment of certain patients with bladder cancer.